August 29, 2016 10:02 PM ET

Life Sciences Tools and Services

Company Overview of Provid Pharmaceuticals, Inc.

Key Executives for Provid Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Gary L. Olson Ph.D.12 RelationshipsChief Executive Officer, President, Chief Scientific Officer and Director--
Edwin J. Thomas 12 RelationshipsChief Financial Officer and Director--
Richard H. Christie M.D., Ph.D.No RelationshipsVice President of Business Development--
Christopher R. Self Ph.D.12 RelationshipsVice President of Medicinal Chemistry and Director--

Provid Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Wolfgang Oster M.D., Ph.D. 38 RelationshipsOncoceutics, Inc.58
Gary L. Olson Ph.D. 12 RelationshipsProvid Pharmaceuticals, Inc.--
Edwin J. Thomas 12 RelationshipsProvid Pharmaceuticals, Inc.--
Christopher R. Self Ph.D. 12 RelationshipsProvid Pharmaceuticals, Inc.--
Warren J. Strittmatter M.D. 29 RelationshipsProvid Pharmaceuticals, Inc.--
View All Board Members

Provid Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
395.4K
Bonus
344.9K
Total Short Term Compensation
509.3K
Total Value of Options
24.8M
Compensation as of Fiscal Year
Provid Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

ChromaDex Corporation Announces Board Changes
August 25, 2016 9:00 PM ET
Icagen, Inc. Appoints Chris Mathes as Chief Commercial Officer
August 25, 2016 1:00 PM ET
Crown Bioscience Inc. Announces Board Appointments
August 25, 2016 12:00 PM ET
Anteo Diagnostics Announces Board Retirements
August 25, 2016 4:49 AM ET
Tyrian Diagnostics Ltd. Announces Board Changes
August 24, 2016 11:57 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Provid Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.